Medpace Holdings Inc
Затворен
СекторЗдравеопазване
458.38 0.52
Преглед
Промяна на цената на акция
24 ч
Минимум
455.98
Максимум
460.92
Приходи | -11M 124M |
|---|---|
Продажби | -1.8M 707M |
P/E Средно за сектора | 29.031 49.712 |
EPS | 4.28 |
Марж на печалбата | 17.53 |
Служители | 6,300 |
EBITDA | -9.5M 154M |
Препоръки | Купи |
|---|---|
12-месечна прогноза | -1.73% downside |
Следващи печалби | 22.07.2026 г. |
|---|
Пазарна капитализация | -1.9B 13B |
|---|---|
Предишно отваряне | 457.86 |
Предишно затваряне | 458.38 |
Настроения в новините
By Acuity
26%
74%
54 / 342 Класиране в Healthcare
Medpace Holdings Inc Графика
Миналото представяне не гарантира бъдещи резултати.
Относно Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.